FEC filings through Oct 14, 2026 · FEC bulk filing data · committee C00380303 · files monthly
SummaryAt a glance
Why it exists
No statement of purpose found on its site.
Money
$53.4K raised, $49.8K spent, $30.5K cash on hand (through Oct 14, 2026). Where it comes from
Who funds it
77% from donors giving over $200 · 23% from donors giving $200 or less · largest donor Christopher Frech, $8.6K. See who funds it
Where it goes
$49.8K given to candidates and committees, the largest to Pete Aguilar ($8K) · 60% of its support to Republicans, 38% to Democrats. See where it goes
Lobbying
Emergent Biosolutions Inc. lobbied on 5 issues. See lobbying
Audits and penalties
1 administrative fine, published by the FEC
Its wordsWhat does this committee say it is for?
No published list of positions
This committee’s site publishes no list of positions we could read, and we found no statement of why it exists. We do not write one for it.
Who it gives toWhich candidates and committees get its money?
Each part reads different filings, so counts and totals can differ.
Party support distribution$37.3K to 17 candidates
Direct PAC contributions and independent expenditures explicitly reported as support, by the party of the candidate they went to.
For candidates $37,250
Republican 60%
Democratic 38%
Support by the party of the candidate
Party of the candidate
Candidates
Direct
Independent
Amount
Share
Republican
11
$22,250
$0
$22,250
60%
Democratic
5
$14,000
$0
$14,000
38%
Other or unresolved
1
$1,000
$0
$1,000
2.7%
Shown support
17
$37,250
$0
$37,250
100%
Contributions are reported money, not endorsements; a PAC giving to both parties is common.
Who this PAC gave to$49,750 in 23 payments
Every contribution on line 23 of the committee’s own Schedule B, which is the filing its summary totals are built from. That line covers federal candidates, party committees and other political committees alike, so a super PAC funding other super PACs appears here rather than under candidate giving.
By recipient
Line 23 contributions by kind and party of recipient
Recipient
Count
Amount
Democratic candidates
5
$14K · 28%
Republican candidates
11
$22.3K · 45%
Other or unresolved candidates
1
$1K · 2%
Other party committees
2
$10K · 20%
Other PACs and committees
1
$2.5K · 5%
All recipients
20
$49.8K
By the candidate’s state
Contributions to candidates by the candidate’s state
State
Candidates
Amount
California
1
$8K
Michigan
1
$3.5K
North Carolina
2
$3.5K
Massachusetts
1
$3K
Oklahoma
1
$2.5K
Kentucky
1
$2.5K
West Virginia
1
$2.5K
Texas
1
$2.5K
The largest 8 of 16 states.
Recipients 20
Show candidate activity and the money network
Candidate and election activity as the recipients filed it
Pete Aguilar2 receipts, latest Mar 17, 2026Pete Aguilar for Congress · H2CA31125$8K
John Moolenaar2 receipts, latest Sep 22, 2025Moolenaar for Congress · H4MI04126$3.5K
Lori Trahan1 receipt, latest Sep 22, 2025Lori Trahan for Congress Committee · H8MA03106$3K
Shelley Moore Capito1 receipt, latest Jul 10, 2025Capito for West Virginia · S4WV00159$2.5K
S. Brett Brett Guthrie1 receipt, latest May 18, 2026Guthrie for Congress · H8KY02031$2.5K
Candidate contribution rows come from candidate committee Schedule A filings, the same rows the party chart above counts.
Committee money network
Money moving between this committee and other committees, matched on FEC committee ID rather than the name each filing was typed under. Both sides exclude memo entries. The figures here count each committee once, from the itemized transfers read for this section, so they will not match the payment counts under Who this PAC gave to.
Committees funding this one
Committees that reported giving to this one on their own Schedule A filings, grouped by the giver’s committee ID.
No committee-to-committee receipts were itemized this cycle.
Committees this one funds
Disbursements this committee itemized to another committee: candidate contributions, party transfers and payments alike, not contributions only.
Committees this one funds
Name
Amount
Pete Aguilar for CongressHouse campaign committee · Connected to AGUILAR LEADERSHIP FUND · 2 payments
Where the money came from $53,363 reported receipts
Itemized (over $200)Donors who have given more than $200 this cycle, so the FEC itemizes (names) them.$41,15577%
Largest donors
Christopher Frech45 contributions, latest Oct 9, 2026 · EXECUTIVE ADVISOR GOVERNMENT AFFAIRS · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$8,640
Joseph PapaOne contribution on Feb 26, 2025 · PRESIDENT AND CEO · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$5,000
Kashfi Anwar-Viveros36 contributions, latest Jun 19, 2026 · HEAD OF SALES - PUBLIC INTEREST · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$4,007
Ronald RichardOne contribution on Jan 22, 2025 · PRESIDENT AND CEO · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$3,000
Marvin L. WhiteOne contribution on Feb 26, 2025 · BOARD OF DIRECTOR · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$2,500
Assal S. Hellmer41 contributions, latest Oct 9, 2026 · VP COMMUNICATIONS · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$2,421
Melissa H. Lochetto37 contributions, latest Aug 14, 2026 · MANAGER TAX · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$2,211
Richard S. Lindahl37 contributions, latest Oct 9, 2026 · EVP AND CHIEF FINANCIAL OFFICER · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$1,406
Joshua J. Reece37 contributions, latest Oct 9, 2026 · VP PROD. GOVERANCE AND BUSINESS PLAN · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$1,258
Matthew C. Fitting33 contributions, latest Oct 9, 2026 · DIRECTOR GOVERNMENT AFFAIRS · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$1,200
William J. Hartzel35 contributions, latest Oct 9, 2026 · SVP MANUFACTURING AND BIOSERVICES · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$1,050
Michelle N. Pepin35 contributions, latest Oct 9, 2026 · SVP HUMAN RESOURCES AND CHRO · EMERGENT BIOSOLUTIONS INC. · GAITHERSBURG, MD$1,050
A donor who gave several times appears once. The 12 largest donors by total given are listed. In all, 596 itemized contributions were filed this cycle, totaling $41K. FEC contributor lists are public records and cannot be used for commercial solicitation.
Unitemized ($200 or less)Donors who have given $200 or less this cycle, so the FEC does not itemize (name) them.$12,20823%
Total reported receipts $53,363
Every dollar the committee reported receiving this cycle, split by the source the FEC filing attributes it to. Open a source marked + to see who gave. FEC filings through Oct 14, 2026.
Who donated: where they live, their employers and jobs
Where the donors live $40,998 placed by state
Loading the map
Tap or hover over a state, or focus the map and use the arrow keys, to read its total. Ctrl or ⌘ and scroll to zoom.
under $1.6K
$1.6K+
$6.6K+
$14.8K+
$26.2K+
none
Top states
Top donor states
Name
Amount
Maryland596 contributions · 100%
$40,998
By the state each contributor wrote on the filing. The FEC aggregates every Schedule A line together, so one committee or organization transfer can account for a whole state. Contributors who have given $200 or less this cycle are not itemized and cannot be placed on a map. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total.
Donors’ employers as filed
Donors’ employers
Employer as filed
Amount
Emergent Biosolutions INC596 contributions · 100% of ranked
$40,998
Itemized receipts grouped by the words contributors filed. The FEC aggregates every Schedule A line here, so committee and organization money sits alongside individuals; this is not an industry classification. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total. Gifts of $200 or less ($12,208) are not itemized, so no employer or occupation is filed for them.
Donors’ occupations as filed
Donors’ occupations
Occupation as filed
Amount
President And CEO
SpendingWhere does the money go?
How the spending splits $49,822 reported
Contributions to candidates and other committeesMoney given to federal candidates, party committees and other PACs.$49,75099.9%
Operating expendituresThe committee's own running costs.$720.1%
Total reported disbursements $49,822
Every dollar this committee reported spending this cycle, split by the lines it reports against. Open a line to see who was actually paid on it. FEC filings through Oct 14, 2026.
What the payments were for $49,750 itemized
Given to othersContributions to other candidates, party committees, and PACs.$49,750100%
Filed as
CONTRIBUTION$49,750
Paid to
Pete Aguilar for Congress$8,000
DSCC$5,000
NRSC$5,000
Moolenaar for Congress$3,500
Lori Trahan for Congress Committee$3,000
Moderate Democrats PAC$2,500
Total itemized disbursements $49,750
Every itemized payment the committee reported this cycle, sorted by what it said each one was for. The categories are ours; the wording they are matched against is the committee’s own. Open a category to read the filed descriptions and who was paid. FEC filings through Oct 14, 2026.
All 23 itemized payments filed this cycle. Spending below the itemization threshold is not filed line by line.
$49.8K spent from Jan 2025 to Oct 2026. Most in one report: $13.5K, May 2026.
$49.8K
Jan 2025Oct 2026
The running total of what the committee’s FEC reports say it spent, independent expenditures included, with a point at the end of each report. The line is straight between reports because a report gives one total for its whole period.
300 PROFESSIONAL DRIVE, SUITE 400GAITHERSBURG, MD, 20879
Audits and penalties
1 administrative fine
Audits and penalties
Published by the Commission against this committee’s own FEC ID. An audit is a periodic examination that reports findings; an administrative fine is a penalty for filing a specific report late or not at all. They are separate instruments and are not combined into a score here.
Source: the Commission’s audit-case and administrative-fine records, joined on this committee’s FEC ID, imported Oct 26, 2026. Enforcement matters (MURs) are published only against respondent names, with no committee identifier, so they are not shown here rather than being matched by name.
LobbyingWhat does its sponsor lobby on?
What Emergent Biosolutions Inc. lobbies on 2026 reports
Besides giving through its PAC, Emergent Biosolutions Inc. pays lobbyists to press Congress and federal agencies. Each quarter it, or a firm it hires, files a public report under the Lobbying Disclosure Act saying which topics it worked on, what it spent, and whom it contacted. This is what those reports say.
Spent on lobbying in 2026
$1.7M
Quarterly reports read
12
Bills it named
4
Topics it lobbied on
Each report files its work under official topics. The bar shows how often each topic came up across the reports; open one to read what was filed under it. Naming a bill says the organization lobbied on it, not which side it took.
Health Issuesin 12 report entries · 4 bills named
In its own words
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
Reauthorization of Protecting Americans from All-Hazards Preparedness Act;
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27;
Opioid crisis legislation, naloxone access and awareness;
State opioid response (SOR) Grant funding FY27;
Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27;
Tribal Opioid Response Grant funding for FY27;
H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone;
H.R. 5252, Having Overdoes Protection Equipment Act;
Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act, Funding for medical countermeasure enterprise including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield, Opioid crisis legislation, naloxone access and awareness, H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act provisions related to biological and chemical defense and access to naloxone.
Providing guidance on development, acquisition and stockpiling of medical countermeasures for the US government.
Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Funding for medical countermeasure enterprise including, SNS, BARDA and Project BioShield;
State Opioid Response (SOR) Grant Funding;
Substance Abuse and Mental Health Block Grant (SABG) funding.
Naloxone access and awareness and opioid prescribing.
Budget/Appropriationsin 9 report entries · 4 bills named
In its own words
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
Reauthorization of Protecting Americans from All-Hazards Preparedness Act;
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27;
Opioid crisis legislation, naloxone access and awareness;
State opioid response (SOR) Grant funding FY27;
Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27;
Tribal Opioid Response Grant funding for FY27;
Disaster Planning/Emergenciesin 6 report entries · 4 bills named
In its own words
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
Reauthorization of Protecting Americans from All-Hazards Preparedness Act;
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27;
Opioid crisis legislation, naloxone access and awareness;
State opioid response (SOR) Grant funding FY27;
Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27;
Tribal Opioid Response Grant funding for FY27;
Homeland Securityin 6 report entries · 4 bills named
In its own words
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD
Defensein 3 report entries · 1 bill named
In its own words
S. 4784, the FY27 National Defense Authorization Act provisions related to biological and chemical defense and access to naloxone.
National Defense Authorization Act for FY2027, provisions related to biological and chemical defense and access to naloxone.
The organization’s own reports give its total lobbying costs, including any firms it hired; each firm reports what this client paid it.
Emergent Biosolutions Inc.Its own staff · 3 reports$1.7M
CGCN Group, LLCLobbying firm · 3 reports$200K
Capitol Counsel LLCLobbying firm · 3 reports$150K
The Nickles Group, LLCLobbying firm · 3 reports$105K
Contributions on the LD-203 report
Reported twice a year by the lobbying filer. $115.3K is political giving that also appears in FEC filings.
Byron Donalds$13K
Banks for Senate$7K
Mike Rogers$7K
Banks PAC$5K
Jim Jordan$5K
Sen. Mike Crapo$5K
Tom Cotton$5K
Julia Letlow$4.5K
John Moolenaar$3.5K
Lindsey Graham$3.5K
Matched by name: these reports are filed for “EMERGENT BIOSOLUTIONS INC.”, found by searching “EMERGENT BIOSOLUTIONS”. Lobbying and FEC records share no ID, so an organization that lobbies under another name is missed. Source: LDA.gov, accessed Oct 26, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Emergent Biosolutions Inc. Employees PAC is registered with the Federal Election Commission as a PAC (qualified). It is a lobbyist/registrant PAC. Its FEC record names Emergent Biosolutions Inc. as an affiliate. Official FEC summary: Federal Election Commission committee record.
Pages quoted 0 pages
No pages quoted
Nothing from this committee’s or its sponsor’s site is quoted yet.
Linked public records
No approved organization identity yet
The official FEC committee record remains available under Filings.
PAPete AguilarDemocratic · U.S. House · CA-33 · via Pete Aguilar For Congress2 payments, latest Mar 17, 2026 · CONTRIBUTION · FEC filing, Mar 17, 2026$8K
LTLori TrahanDemocratic · U.S. House · MA-03 · via Lori Trahan For Congress Committee1 payment, latest Sep 22, 2025 · CONTRIBUTION · FEC filing, Sep 22, 2025$3K
Mullin for AmericaSenate campaign committee · Connected to MULLIN VICTORY FUND · 1 payment
$2.5K
Guthrie for CongressHouse campaign committee · Connected to LANGWORTHY LEADERSHIP & ACCOUNTABILITY FUND · 1 payment
$2.5K
Capito for West VirginiaSenate campaign committee · Connected to 2026 SENATORS CLASSIC COMMITTEE · 1 payment
$2.5K
Dan Crenshaw for CongressHouse campaign committee · Connected to DAN CRENSHAW VICTORY COMMITTEE · 1 payment
$2.5K
Hudson for CongressHouse campaign committee · Connected to PIT CREW FUND · 1 payment
$2.5K
Bill Cassidy for US SenateSenate campaign committee · Connected to 2026 SENATORS CLASSIC COMMITTEE · 2 payments
$2K
$49.8K across 20 recipient committees, or 99.9% of everything this committee reports spending. The largest 12 are shown.
Built from FEC Schedule A and Schedule B filings for the selected cycle. A committee only appears here if the money was itemized under its FEC committee ID.
2 contributions · 20% of ranked
$8,000
Executive Advisor Government Affairs33 contributions · 15% of ranked
$6,336
Head Of Sales - Public Interest36 contributions · 9.8% of ranked
$4,007
Board Of Director1 contribution · 6.1% of ranked
$2,500
VP Communications41 contributions · 5.9% of ranked
$2,421
Executive Advisor Government Affair12 contributions · 5.6% of ranked
$2,304
Manager TAX37 contributions · 5.4% of ranked
$2,211
EVP And Chief Financial Officer37 contributions · 3.4% of ranked
$1,406
Itemized receipts grouped by the words contributors filed. The FEC aggregates every Schedule A line here, so committee and organization money sits alongside individuals; this is not an industry classification. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total. Gifts of $200 or less ($12,208) are not itemized, so no employer or occupation is filed for them.
The people, firms and committees paid the most, across every kind of payment. Each share is of everything the committee reported spending this cycle, not only the itemized payments above. A payee that is itself a committee links to its own profile.
H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone;
H.R. 5252, Having Overdoes Protection Equipment Act;
Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield.
Opioid and heroin addiction legislation, naloxone access and awareness.
H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone;
H.R. 5252, Having Overdoes Protection Equipment Act;
Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act;
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27;
Opioid crisis legislation, naloxone access and awareness;
State opioid response (SOR) Grant funding FY27;
Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27;
Tribal Opioid Response Grant funding for FY27;
H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone;
H.R. 5252, Having Overdoes Protection Equipment Act;
Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD).
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act